DTIL•benzinga•
Precision Biosciences Plans To Present Preclinical Data Supporting Advancement Of PBGENE-HBV Into Clinical Development, Company Says It Will Also Outline Design Of Its First-in-human Study, ELIMINATE-B In Patients With Chronic Hepatitis B
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 15, 2024 by benzinga